Lara Stepan

1.2k total citations
7 papers, 318 citations indexed

About

Lara Stepan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lara Stepan has authored 7 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Lara Stepan's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (2 papers) and Stress Responses and Cortisol (1 paper). Lara Stepan is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (2 papers) and Stress Responses and Cortisol (1 paper). Lara Stepan collaborates with scholars based in United States, Switzerland and Japan. Lara Stepan's co-authors include Luís Borges, Claire L. Sutherland, Esther S. Trueblood, John S. Babcook, Kari Hale, Leeanne Zalameda, John D. McCarter, David Meininger, Yichin Liu and Damir Vidović and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Cancer.

In The Last Decade

Lara Stepan

7 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Stepan United States	6	167	95	77	63	50	7	318
Radhakrishna G. Pillai United Kingdom	7	71 0.4×	92 1.0×	79 1.0×	144 2.3×	61 1.2×	13	373
Cheng-Ying Wu United States	5	74 0.4×	170 1.8×	39 0.5×	9 0.1×	113 2.3×	7	315
Carina M. Thomé Germany	9	49 0.3×	85 0.9×	37 0.5×	10 0.2×	66 1.3×	13	322
Manu Pandey United States	8	107 0.6×	51 0.5×	7 0.1×	10 0.2×	64 1.3×	25	239
Junfeng Xu China	11	64 0.4×	129 1.4×	21 0.3×	9 0.1×	18 0.4×	27	270
Anna Bielecka-Kowalska Poland	10	32 0.2×	225 2.4×	27 0.4×	23 0.4×	8 0.2×	15	328
April Bell United States	5	60 0.4×	70 0.7×	54 0.7×	2 0.0×	103 2.1×	10	236
Lloyd Bod France	8	74 0.4×	55 0.6×	20 0.3×	4 0.1×	141 2.8×	10	247
Ivana Apicella United States	10	29 0.2×	144 1.5×	12 0.2×	40 0.6×	57 1.1×	16	259
Laura Barbieri Sweden	9	111 0.7×	112 1.2×	9 0.1×	4 0.1×	127 2.5×	13	332

Countries citing papers authored by Lara Stepan

Since Specialization

Citations

This map shows the geographic impact of Lara Stepan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Stepan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Stepan more than expected).

Fields of papers citing papers by Lara Stepan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Stepan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Stepan. The network helps show where Lara Stepan may publish in the future.

Co-authorship network of co-authors of Lara Stepan

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Stepan. A scholar is included among the top collaborators of Lara Stepan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Stepan. Lara Stepan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Kamdar, Manali, Scott R. Solomon, Jon Arnason, et al.. (2024). Lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) with salvage chemotherapy (CT) followed by autologous stem cell transplantation (ASCT) as second-line (2L) treatment in patients (pt) with R/R large B-cell lymphoma (LBCL): 3-year follow-up (FU) from the randomized, phase 3 TRANSFORM study.. Journal of Clinical Oncology. 42(16_suppl). 7013–7013. 6 indexed citations

Stepan, Lara, Sahar Ansari, Ethan Thompson, et al.. (2023). Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study. Blood. 142(Supplement 1). 225–225. 3 indexed citations

Makita, Shinichi, Go Yamamoto, Dai Maruyama, et al.. (2022). Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma. Cancer Medicine. 11(24). 4889–4899. 17 indexed citations

Meininger, David, Leeanne Zalameda, Yichin Liu, et al.. (2011). Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1814(12). 1947–1954. 88 indexed citations

Stepan, Lara, Esther S. Trueblood, Kari Hale, et al.. (2011). Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues. Journal of Histochemistry & Cytochemistry. 59(7). 701–710. 179 indexed citations

Vidović, Damir, Thomas J. Graddis, Lara Stepan, Dennis M. Zaller, & Reiner Laus. (2003). Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC. Human Immunology. 64(2). 238–244. 9 indexed citations

Vidović, Damir, Thomas J. Graddis, Feng Chen, et al.. (2002). Antitumor vaccination with HER‐2‐derived recombinant antigens. International Journal of Cancer. 102(6). 660–664. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact